Invasive group-A streptococcal infection in an allograft recipient: A case report

Journal of Bone and Joint Surgery

Volumn 89, Issue 9, 2007, Pages 2044-2047

  Lee, Ellen H ^a,b   Ferguson, Dayna ^a   Jernigan, Daniel ^b   Greenwald, Melissa ^c   Coté, Timothy ^c   Bos, Jon E ^d   Guarner, Jeannette ^e   Zaki, Sherif ^e   Schuchat, Anne ^b   Beall, Bernard ^b   Srinivasan, Arjun ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d OKLAHOMA STATE DEPARTMENT OF HEALTH   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN;

ADOLESCENT; ALLOGRAFT; ARTHROTOMY; ARTICLE; CASE REPORT; FASCIOTOMY; FEVER; GRAFT RECIPIENT; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVENOUS CATHETER; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; ALLOTRANSPLANTATION; ANTERIOR CRUCIATE LIGAMENT; BACTEREMIA; CADAVER; CLASSIFICATION; DONOR; MICROBIOLOGY; PATELLA LIGAMENT; PHYSIOLOGY; STREPTOCOCCUS PYOGENES; SURGICAL INFECTION; TISSUE PRESERVATION; TRANSPLANTATION;

ADOLESCENT; ANTERIOR CRUCIATE LIGAMENT; BACTEREMIA; CADAVER; HUMANS; MALE; PATELLAR LIGAMENT; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SURGICAL WOUND INFECTION; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TISSUE PRESERVATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 85047683201     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200709000-00023     Document Type: Article

References (18)

1. American Association of Tissue Banks. 2003 Annual Tissue Bank Survey. McLean, VA: American Association of Tissue Banks; 2003.
2. Vangsness CT Jr, Garcia IA, Mills CR, Kainer MA, Roberts MR, Moore TM. Allograft transplantation in the knee: tissue regulation, procurement, processing, and sterilization. Am J Sports Med. 2003;31:474-81.
3. Centers for Disease Control and Prevention (CDC). Septic arthritis following anterior cruciate ligament reconstruction using tendon allografts - Florida and Louisiana, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:1081-3.
4. Centers for Disease Control and Prevention (CDC). Update: unexplained deaths following knee surgery - Minnesota, 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1080.
5. Centers for Disease Control and Prevention (CDC). Update: allograft-associated bacterial infections - United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:207-10.
6. Kuehnert MJ, Clark E, Lockhart SR, Soll DR, Chia J, Jarvis WR. Candida albicas endocarditis associated with a contaminated aortic valve allograft: implications for regulation of allograft processing. Clin Infect Dis. 1998;27:688-91.
7. Kainer MA, Linden JV, Whaley DN, Holmes HT, Jarvis WR, Jemigan DB, Archibald LK. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med. 2004;350:2564-71.
8. Guarner J, Jernigan JA, Shieh WJ, Tatti K, Flannagan LM, Stephens DS, Popovic T, Ashford DA, Perkins BA, Zaki SR; Inhalational Anthrax Pathology Working Group. Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol. 2003;163:701-9.
9. Guarner J, Greer PW, Whitney A, Shieh WJ, Fischer M, White EH, Carlone GM, Stephens DS, Popovic T, Zaki SR. Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays. Am J Clin Pathol. 2004;122:754-64.
10. Moody MD, Padula J, Lizana D, Hall CT. Epidemiologic characterization of group A streptococci by t-agglutination and m-precipitation tests in the public health laboratory. Health Lab Sci. 1965;2:149-62.
11. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, Kriz P, Lovgren M, Martin D, Schwartz B, Totolian A, Bessen D, Hollingshead S, Rubin F, Scott J, Tyrell G. emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis. 1999;5:247-53.
12. Li Z, Sakota V, Jackson D, Franklin AR, Beall B; Active Bacterial Core Surveillance/Emerging Infections Program Network. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J Infect Dis. 2003;188:1587-92.
13. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis. 2002;35:268-76.
14. Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). Rockville, MD: Food and Drug Administration, Center for Biologies Evaluation and Research; 2004.
15. Rigney PR. American Association of Tissue Banks Bulletin No. 04-46. McLean, VA: American Association of Tissue Banks; 2004.
16. Martinez O. University of Miami Tissue Bank. Personal communication. October 2003.
17. U.S. Food and Drug Administration. Questions and answers for roll-out of good tissue practice (GTP) final rule. http://www.fda.gov/cber/rules/gtpq&a. htm. Accessed 2007 Jun 15.
18. Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis. 2002;35:950-9.